CVS Health Corporation (NYSE:CVS) Short Interest Down 13.4% in January

CVS Health Corporation (NYSE:CVS) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 18,762,000 shares, a decrease of 13.4% from the December 31st total of 21,665,261 shares. Based on an average daily trading volume, of 7,566,253 shares, the days-to-cover ratio is currently 2.5 days. Approximately 1.5% of the shares of the company are sold short. Approximately 1.5% of the shares of the company are sold short. Based on an average daily trading volume, of 7,566,253 shares, the days-to-cover ratio is currently 2.5 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. National Pension Service increased its position in CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after buying an additional 119,189 shares during the last quarter. AE Wealth Management LLC grew its stake in shares of CVS Health by 6.2% during the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after acquiring an additional 14,983 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its holdings in CVS Health by 11.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after acquiring an additional 22,653 shares during the last quarter. Alpha Omega Wealth Management LLC raised its stake in CVS Health by 12.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its position in CVS Health by 186.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock worth $30,568,000 after purchasing an additional 258,050 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS traded down $0.72 during trading hours on Wednesday, hitting $76.11. 3,342,731 shares of the stock were exchanged, compared to its average volume of 9,881,976. The company’s fifty day simple moving average is $78.82 and its two-hundred day simple moving average is $75.43. The company has a market cap of $96.62 billion, a PE ratio of 200.56, a price-to-earnings-growth ratio of 0.69 and a beta of 0.50. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health has a 1-year low of $53.36 and a 1-year high of $85.15.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s payout ratio is 700.00%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent research reports. Wells Fargo & Company reduced their target price on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Mizuho lifted their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Bank of America cut their price objective on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a report on Tuesday, January 27th. Robert W. Baird raised their target price on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Finally, Wolfe Research lifted their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, December 8th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.